Polymerase chain reaction in the diagnosis and monitoring of patients with PML-RAR alpha and PLZF-RAR alpha gene rearrangement in acute promyelocytic leukaemia
Medical Services Advisory Committee
Record ID 32003001186
English
Authors' objectives:
This review aims to assess the effectiveness of polymerase chain reaction (PCR) testing in the diagnosis and monitoring of acute promyelocytic leukaemia (APL).
Authors' recommendations:
MSAC recommended that on the strength of evidence pertaining to safety, effectiveness and cost effectiveness of polymerase chain reaction (PCR) testing in the diagnosis and monitoring of acute promyelocytic leukaemia (APL), public funding should be supported for this procedure.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Costs and Cost Analysis
- Polymerase Chain Reaction
- Leukemia, Promyelocytic, Acute
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medicare Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.